Clinical Trial

Correlation Study Between the Classification of Arthrogenic Motor Inhibition (AMI) and Clinical Assessment After ACL Rupture

Study acronym: AMIVAL
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this interventional study is to measure medial vastus inhibition and associate it with AMI classification in patients with ACL rupture. The main question it aims to answer is: Is there a correlation between AMI classification and clinical assessment after ACL rupture ? Participants will undergo surface EMG and Myotonometry.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-18.
Trial Details
NCT Number NCT06945133
Lead Sponsor GCS Ramsay Santé pour l'Enseignement et la Recherche
Conditions ACL - Anterior Cruciate Ligament Rupture
Enrollment 90 participants
Start Date 2025-12-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-11-19